Treatment with HGF-neutralising antibody + c-MET inhibitor (Hi + Ci), as well as gemcitabine in combination with HGF/c-MET inhibition (Hi + Ci + G) significantly increased apoptosis of cancer cells. Here, MET is linked to cancer.